| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000040019 |
| Receipt No. | R000045626 |
| Scientific Title | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy |
| Date of disclosure of the study information | 2020/04/14 |
| Last modified on | 2020/04/24 (Ver. 4) |
| Basic information | ||
| Public title | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy | |
| Acronym | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy | |
| Scientific Title | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy | |
| Scientific Title:Acronym | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy | |
| Region |
|
|
| Condition | ||
| Condition | pulmonary malignancy | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To analyze the short- and long-term postoperative outcomes of robot-assisted surgery in respiratory surgery and to establish the utility and safety of robot-assisted surgery in respiratory surgery. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of postoperative complications |
| Key secondary outcomes | Robotic surgery completion rate, intraoperative blood loss, operative time, length of hospital stay, medical costs, recurrence-free survival and overall survival |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Robotic-assisted surgery is performed using the da Vinci Surgical System x, and the target procedure is "thoracoscopic pulmonary malignancy surgery (resection of the lung lobes or more than one lung lobe with endoscopic surgical support equipment). It is. The treatment and diagnostic policies and the extent of lymph node dissection for lung cancer are in accordance with the 2018 edition of the Lung Cancer Practice Guidelines. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | PS (Performance Status) is 0 or 1.
No prior treatment for the disease. Consent to participate in the study has been obtained in writing. Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination. In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II. In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung. |
|||
| Key exclusion criteria | PS (Performance Status) is 0 or 1.
No prior treatment for the disease. Consent to participate in the study has been obtained in writing. Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination. In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II. In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | The Division of Thoracic Surgery, the Department of Surgery | ||||||
| Zip code | 105-8461 | ||||||
| Address | University Hall 2, 3-25-8, Nishi-Shimbashi, Minato-ku | ||||||
| TEL | 0334331111 | ||||||
| hideki.matsudaira@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | The Division of Thoracic Surgery, the Department of Surgery | ||||||
| Zip code | 105-8461 | ||||||
| Address | University Hall 2, 3-25-8, Nishi-Shimbashi, Minato-ku | ||||||
| TEL | 0334331111 | ||||||
| Homepage URL | |||||||
| hideki.matsudaira@gmail.com | |||||||
| Sponsor | |
| Institute | he Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Jikei University School of Medicine |
| Address | 3-25-8, Nishi-Shimbashi, Minato-ku |
| Tel | 0334331111 |
| rinri@jikei.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045626 |